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  Twelve Korean infectious bronchitis viruses (IBVs) were 
isolated in the field from chickens suspected of being car-
riers of infectious bronchitis between 2001 and 2003. The 
S1 glycoprotein genes of these IBV isolates were amplified 
by reverse transcriptase-polymerase chain reaction (RT- 
PCR) and analyzed by restriction fragment length poly-
morphism  (RFLP)  analysis.  These  Korean  IBV  isolates 
were classified into  three groups according to their RFLP 
patterns  obtained  using  the  restriction  enzyme  HaeIII. 
Half of the twelve isolates were similar to the KM91 RFLP 
pattern, which is a common pattern in Korea. Three more 
isolates were related to the Arkansas strain pattern, but 
w i t h  s o m e  u n i q u e  v a r i a t i o n s .  T h e  o t h e r  t h r e e  v i r u s e s  
showed variant RFLP patterns. For a comparison with the 
published sequences for non-Korean IBV strains, ampli-
fied PCR products from the twelve isolates were cloned 
and sequenced. The Korean IBV field isolates had 71.2- 
99.7% nucleotide sequence homology with each other and 
45.9-80.7% nucleotide sequence homology with non-Korean 
IBV strains. With respect to the deduced amino acid se-
quence, the Korean IBV isolates had 71.5-99.3% similarity 
with  each  other  and  44.9-80.3%  similarity  with  non- 
Korean  IBV  strains.  Phylogenetic  tree  analysis  revealed 
that some of the IBV isolates appear to belong to a new 
group, different from the non-Korean IBV strains or from 
previously isolated Korean IBV strains.  Specifically, the 
new Korean IBV isolates K10217-03, K3-3 and K1255-03 
represented a separate group. These findings suggest that 
the Korean IBVs appear to be continuously evolving. 
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Introduction 
  The avian infectious bronchitis virus (IBV) causes eco-
nomically important upper respiratory and urogenital tract 
diseases in chickens, resulting in tracheal rales, sneezing, 
coughing, reduced weight gain, and reduction of egg pro-
duction [5]. IBV, the causative agent of infectious bronchi-
tis (IB), belongs to the family Coronaviridae and is found 
worldwide [5,15]. The genome of IBV consists of a sin-
gle-stranded sense RNA genome encoding four structural 
proteins, which are envelope glycoprotein, integral mem-
brane glycoprotein, phosphorylated nucleocapsid protein, 
and spike (S) glycoprotein [15,22]. 
  The S glycoprotein is cleaved post-translationally by cel-
lular proteases into the S1 and S2 subunits [4]. The glob-
ular S1 subunit forms the tip of a spike, extending outward, 
whereas the S2 subunit anchors the S1 moiety to the viral 
membrane [1]. The S1 subunit is involved in viral in-
fectivity, virus-neutralizing epitopes, serotype-specific se-
quences, and hemagglutinin activity [1-3,11,12].
  Different serotypes and subtypes of IBV have been re-
ported worldwide, including in Korea [8,9,14,17-19,21]. 
Various serotypes are thought to develop by  nucleotide in-
sertions, deletions,  point mutations, and by RNA recombi-
nation in the S1 subunit [10,13,23,24]. Since IBV was first 
reported in Korea in 1986 and nephropathogenic IBV was 
recognized in 1990, a variety of serotypes of IBV have 
been reported in Korea [17]. Some of these IBV isolates 
exhibit variant patterns that distinguish them from each 
other and from non-Korean IBV isolates in analysis by re-
verse transcriptase-polymerase chain reaction-restriction 
fragment length polymorphism (RT-PCR-RFLP) [17].
  The objective of this study was genetic characterization 
of recent IBV isolates in Korea. The S1 glycoprotein genes 
of the Korean IBVs were amplified by RT-PCR. Amplified 
S1 genes were classified by RFLP analysis and cloned, se-
quenced and compared to other non-Korean published IBV 
sequences. By RT-PCR-RFLP and phylogenetic tree anal-402    Ji-Hyun Jang et al.
Table 1. History of Korean IBV field isolates, RFLP patterns and GenBank accession numbers
    IBV   isolates
Organs*used for virus 
isolation
Chicken type
† Age of IB outbreak
(days)
PCR-RFLP patterns
GenBank
accession
numbers
 1.
 2.
 3.
 4.
 5.
 6.
 7.
 8.
 9.
10.
11.
12.
K434-01
K748-01
K058-02
K044-02
K117-02
K234-02
K545-02
K514-03
K10217-03
K1255-03
K3-3
K2-6
CT
K
T
K
T
T
K
CT
K
CT
K
CT
B
B
B
B
B
B
BB
BB
BB
BB
B
BB
28
37
70
60
70
16
14
14
35
14
-
§
-
Arkansas
 KM91
‡
KM91
KM91
KM91
KM91
Variant
KM91
Variant
Variant
Variant
Variant
AY790368
AY790359
AY790360
AY790358
AY790362
AY790361
AY790366
AY790365
AY790363
AY790364
AY790367
AY790369
*K = kidney, T = trachea, CT = cecal tonsil. 
†B = broiler, BB = broiler breeder. 
‡KM91 was the representative isolate of Korean IBV isolates
determined as genotype III which showed a distinct RFLP pattern in PCR-RFLP analysis [21].
 §Unidentified.
ysis, recent Korean IBV isolates were classified at the ge-
netic level into three distinct groups, two of which included 
only indigenous Korean IBV isolates and one of which rep-
resented a new phylogenetic group.
Materials and Methods
Viruses
  Twelve IBVs were isolated and propagated from the kid-
ney, trachea and cecal tonsil of suspected IB carriers be-
tween 2001 and 2003 using embryonated SPF chicken 
eggs according to the standard procedure [7]. The history 
of these isolates is shown in Table 1. 
RNA isolation and RT-PCR
    All procedures for RNA isolation and reverse tran-
scriptase-polymerase chain reaction (RT-PCR) were pre-
viously described [14]. Viral RNA was isolated and puri-
fied from allantoic fluid collected from embryonated SPF 
chicken eggs inoculated with IBV isolates using the 
QIAamp MinElute Virus Spin Kit (QIAGEN, USA). 
  Amplification of the S1 gene by RT-PCR was performed 
using one of the forward primers S1OLIGO5' (5'TGA 
AAACTGAACAAAAGA3') or NEWS1OLIGO5' (5'TG 
AAAACTGAACAAAAGAC3') together with one of the 
reverse primers S1OLIGO3' (CTAAACTAACATAAGGG 
C3') or degenerate3'-2 (5'CCATAAGTAACATAAGGG 
CAA3') [14,16]. The RT reaction for synthesis of cDNA 
consisted of purified RNA, 20 pmol S1 OLIGO3' or degen-
erate 3'-2 primer and RT PreMix AccuPower RT PreMix 
(Bioneer, Korea). The mixture was incubated at 42°C for 
60 min, and then heated for 5 min at 94°C to stop the 
reaction. For the PCR reaction, 20 pmol each primer and 
cDNA were added to the AccuPower PCR PreMix 
(Bioneer, Korea). The PCR was performed with 35 cycles 
of denaturation at 94°C for 90 sec, annealing at 45°C for 30 
sec, polymerization at 72°C for 90 sec and a final polymer-
ization step at 72°C for 10 min. The PCR products were an-
alyzed on a 1.0% agarose gel. The predicted size of the 
PCR products was about 1,720 bp [14,16].
RFLP analysis
  Amplification products were excised from an agarose gel 
and purified using the GENECLEAN Turbo Kit (Qbio-
gene, USA). The restriction enzyme HaeIII was used to di-
gest the S1 gene amplification product as previously de-
scribed [14,17], and the resulting RFLP patterns were ob-
served after electrophoresis on a 2% agarose gel.
Cloning and sequencing
  Twelve IBV isolates selected after RFLP analysis were 
sequenced. PCR products were cut from 1% agarose gels 
and purified using the GENECLEAN Turbo Kit (Qbio-
gene, USA). Purified PCR products were then cloned into 
the pGEM-T Easy Vector (Promega, USA) and trans-
formed into JM 109 competent cells (Promega, USA). The 
cells carrying recombinant plasmids were selected on 
Luria-Bertani agar plates containing ampicillin, X-gal and 
IPTG, and plasmid DNA for sequencing was prepared us-
ing the E.Z.N.A plasmid miniprep Kit I (Omega Bio-tec, 
USA). Sequencing was performed with T7 and SP6 pro-
moter primers using an ABI PRISM 3700 DNA Analyzer 
(Applied Biosystems, USA). For each IBV isolate, two or 
three independent clones originating from different PCR S1 sequences of Korean IBVs    403
Table 2. Comparison of the nucleotide and deduced amino acid sequences of the S1 glycoprotein gene of 12 Korean IBV isolates and
non-Korean strains
Percent similarity-amino acids
   1       2        3       4        5         6        7        8        9      10      11       12      13      14     15      16       17     18       19      20     21       22
1. K10217-03 ***   97.6   85.2   97.6   72.6   83.9   84.6   83.9   72.2   84.7   73.9   84.5   83.6   73.0   85.0   75.4   74.4   75.4   73.0   73.7   74.9   45.6
2. K1255-03 99.0   ***   84.7   97.8   72.2   83.3   84.3   83.5   71.9   84.5   73.3   84.3   83.5   72.4   84.5   74.7   73.7   74.7   72.4   72.6   74.5   44.9
3. K514-03 84.0   84.0   ***   84.9   75.1   95.5   96.6   94.8   74.6   95.9   76.1   95.9   93.1   75.0   99.1   79.3   78.5   79.6   75.0   74.4   77.8   45.6
4. K3-3 98.8   98.6   83.6   ***   71.9   83.5   84.4   83.5   71.5   84.5   73.2   84.3   83.5   72.3   84.7   74.7   73.6   74.7   72.3   72.6   74.3   45.6
5. K2-6 71.9   71.7   73.8   71.3   ***   77.4   75.7   74.8   96.7   76.6   85.5   76.4   75.1   85.1   75.0   76.7   74.0   75.4   77.5   74.2   75.4   44.9
6. K044-02 83.0   82.9   96.0   82.5   76.7   ***   95.2   93.1   76.8   94.4   78.3   94.4   92.0   77.6   95.5   80.3   78.5   80.3   76.8   76.1   79.3   45.6
7. K058-02 84.1   84.1   97.9   83.8   75.9   96.8   ***   96.5   75.2   95.3   75.6   95.3   93.1   74.6   96.4   80.1   78.5   80.3   74.6   74.8   78.4   46.2
8. K234-02 84.0   84.0   97.0   83.7   75.2   96.1   98.1   ***   74.3   95.5   75.0   95.5   92.4   74.1   94.6   79.3   78.1   79.7   73.7   73.7   78.4   46.2
9. K545-02 71.8   71.5   75.1   71.2   98.3   76.2   75.4   74.7   ***   75.7   86.0   75.7   74.5   85.5   74.6   76.5   73.5   75.2   77.0   74.0   75.4   45.2
10. K117-02 84.2   84.1   97.5   83.9   74.2   94.9   97.5   97.9   75.6   ***   75.7   99.3   92.5   74.8   95.7   78.7   77.9   78.9   74.6   75.0   78.0   45.4
11. K434-01 72.2   72.0   76.0   71.6   99.7   77.1   76.2   75.6   98.6   76.6   ***   75.5   75.1   97.2   75.7   77.7   74.6   76.4   79.6   76.1   75.6   44.9
12. K748-01 83.9   83.9   97.4   83.7   74.0   94.8   97.4   97.9   75.4   99.7   76.4   ***   92.5   74.6   95.7   78.5   77.9   78.9   74.4   74.8   78.0   45.6
13. K774-01 83.3   83.3   95.6   83.0   75.7   94.8   95.7   95.8   75.0   95.6   76.0   95.5   ***   74.0   92.9   79.0   77.9   79.5   74.0   74.3   78.0   45.4
14. K281-01 72.7   72.4   76.8   72.3   86.3   78.4   76.7   76.5   86.8   75.6   86.6   75.3   75.9   ***   74.6   76.5   73.7   75.2   79.6   75.3   74.9   44.7
15. K069-01 84.0   84.0   99.6   83.6   73.8   97.9   97.9   97.1   75.1   97.5   76.1   97.4   95.7   76.8   ***   79.3   78.5   79.6   74.6   74.4   78.0   45.6
16. BEAU 74.3   73.9   79.9   73.9   76.2   80.4   80.2   79.8   76.0   80.0   76.6   79.9   79.5   76.0   79.9   ***   93.1   96.1   75.2   79.1   88.9   46.7
17. MASS41 73.5   73.3   79.0   72.4   74.5   79.0   78.6   78.2   74.6   77.9   74.9   77.9   79.2   75.0   78.9   96.6   ***   94.2   73.5   78.3   89.1   46.9
18. H120 74.2   74.0   80.4   73.9   75.2   80.7   80.4   79.9   74.9   80.1   75.5   80.0   79.8   75.6   80.5   97.3   96.3   ***   74.3   78.8   90.4   47.1
19. ARK99 71.7   71.4   72.1   71.0   77.0   75.3   74.0   73.7   77.1   72.6   77.3   72.4   73.7   78.8   74.1   74.9   75.0   74.1   ***   77.9   73.5   44.1
20. GRAY 71.7   71.4   74.4   71.2   75.0   75.8   75.6   75.2   75.0   75.2   75.3   75.0   75.2   75.4   74.5   79.8   80.5   80.9   79.1   ***   76.8   44.5
21. CONN 73.7   73.5   75.4   73.4   75.0   79.2   74.3   74.4   75.6   75.6   75.4   75.6   73.9   73.9   75.4   93.8   93.7   93.7   72.2   77.8   ***   46.6
22. DE072 46.3   45.9   48.0   48.6   45.9   50.0   48.7   48.0   47.5   47.9   47.9   48.0   49.5   47.1   47.7   52.8   49.5   52.0   48.0   47.2   46.8   ***
Percent similarity-Nucleotide
Fig. 1. RFLP patterns of the PCR-amplified S1 glycoprotein 
genes from representative Korean IBV isolates digested with re-
striction enzyme Hae III. Lanes 1: 100 bp plus DNA ladder; Lane
2: K044-02; Lane 3: K434-01; Lane 4: K 3-3; Lane 5: K2-6; Lane
6: K545-02.
reactions were sequenced in order to guard against the pos-
sibility of errors arising during the RT-PCR or cloning 
steps.
Sequence analysis
  Nucleotide sequence data were compiled and analyzed 
using the Clustal V method in MegAlign software (DNA 
Star, USA). A phylogenetic tree for the S1 glycoprotein 
was generated using the maximum parsimony method with 
100 bootstrap replicates in a heuristic search with the 
PAUP 4.0 software program (Sinauer Associates, USA).
  The sequence data for the S1 gene reported in this paper 
were added to the GenBank database (Table 1). Sequences 
used for comparison or phylogenetic analysis in this study 
were obtained from the following GenBank database ac-
cession numbers: Arkansas 99 (M85244), Beaudette (X 
02342), Connecticut (L18990), DE072 (U77298), Gray 
(L14069), H120 (M21970), Mass 41 (X04722), KM91 
(EF621369), K069-01 (AY257061), K281-01 (AY257062), 
and K774-01 (AY257065).404    Ji-Hyun Jang et al.
Fig. 2. The deduced amino acid sequences of the S1 glycoprotein gene of 13 Korean IBV isolates and six published non-Korean IBV
strains. The dashes (-) indicate regions where the sequences are identical to those of K748-01. Deletions within the sequences are shown
with asterisks (*).S1 sequences of Korean IBVs    405
Fig. 3. Phylogenetic relationship based on the deduced amino 
acid sequences of the S1 glycoprotein of the 12 Korean IBV field
isolates (K434-01, K748-01, K058-02, K044-02, K117-02, 
K234-02, K545-02, K514-03, K10217-03, K1255-03, K3-3, 
K3-3) and non-Korean IBV strains generated by maximum parsi-
mony method with heuristic search and 100 bootstrap replicates.
The length of each branch represents the number of amino acid 
changes between sequences.
Results
RT-PCR-RFLP
  The initial classification of the IBV isolates was accom-
plished by RT-PCR-RFLP analysis. Twelve Korean IBVs 
were separated into four groups by RFLP analysis (Fig. 1). 
Six of the twelve isolates (K748-01, K044-02, K058-02, 
K234-02, K117-02, and K514-03) had the same RFLP pat-
tern as the IBV KM91 strain, which was isolated in 1991 in 
Korea [17]. The RFLP pattern for isolate K434-01 corre-
sponded to an IBV Arkansas strain. The RFLP patterns of 
the K2-6 and K545-02 isolates were related to the Arkan-
sas strain but had unique patterns [14,17]. Three of the 
Korean IBVs (K10217-03, K3-3 and K1255-03) generated 
an identical but variant RFLP pattern.
Sequencing and sequence analysis
  The S1 gene of the 12 Korean IBV strains was sequenced 
to characterize the isolates. The nucleotide and deduced 
amino acid sequences of those IBV isolates were de-
termined and compared with the sequences of published 
non-Korean IBV strains (Table 2, Fig. 2).
  Korean IBVs had nucleotide sequence identities of be-
tween 71.2% (K545-02 and K3-3) and 99.7% (K748-01 
and K117-02) with each other and  between 45.9% (DE072 
and K2-6) and 80.7% (H120 and K044-02) with non- 
Korean IBVs. Korean IBVs had amino acid sequence sim-
ilarities of between 71.5% (K545-02 and K3-3) and 99.3% 
(K748-01 and K117-02) with each other and between 
44.9% (DE072 and K2-6) and 80.3% (BEAU and K044- 
02) with non-Korean IBVs. 
  The deduced amino acid sequences of Korean IBVs were 
aligned with the sequences of published Korean and 
non-Korean strains (Fig. 2). Most variations were ob-
served among residues 53-96, 115-163 and 268-398 (num-
bering is with reference to the Mass41 strain).
  A phylogenetic tree was constructed from the nucleotides 
and deduced amino acid sequences of the S1 glycoprotein 
genes of the Korean and non-Korean IBVs (Fig. 3). The 
twelve Korean IBVs were grouped into three distinct 
clusters. Recent IBV isolates K10207-03, K3-3 and 
K1255-03 formed the first independent branch. The six ad-
ditional IBVs K514-03, K044-02, K058-02, K234-02, 
K117-02, and K748-01 formed the second group, along 
with the K069-01 and K774-01 strains that were grouped 
into the KM91 type previously [17]. Finally, the K2-6, 
K434-01 and K545-02 isolates formed a third group that 
was related to the IBV Ark99 and Gray strains. 
Discussion
  Although a Mass-type live attenuated vaccine and in-
activated vaccine have been widely used  to control IB, the 
disease has continued to be a problem in Korea. Twelve 
Korean IBVs were analyzed in this study, first by 
RT-PCR-RFLP and then by nucleotide sequencing of the 
S1 glycoprotein gene.
  The Korean IBV field isolates were studied between 1986 
and 1997 and were characterized using RT-PCR-RFLP 
analysis and pathogenicity testing, but the sequences of 
those viruses were not reported [21]. According to those 
prior analyses, the KM91 type is the most common or re-
presentative genotype III among the five genotypes. KM91 
yielded distinct RFLP patterns in the PCR-RFLP analysis 
using the restriction enzymes Hae III, Eco RI and Bam HI. 
For the pathogenicity testing, the isolate KM91 was asso-
ciated with 50% mortality, severe nephritis and renal urate 
deposits in the kidneys of infected chicks, whereas the oth-
er strains merely caused respiratory distress one to two 
days after inoculation [21]. The H120 vaccine could not 
protect the chicks against the challenge with the KM91 iso-406    Ji-Hyun Jang et al.
late [21]. In the RT-PCR-RFLP analysis of the recent IBV 
isolates, 10 of 15 IBVs produced RFLP patterns corre-
sponding to the IBV KM91 strain [17]. Therefore, IBV 
KM91 seems to be the major IBV in Korea. 
  In this study, half of the 12 Korean IBV isolates (K748- 
01, K044-02, K058-02, K117-02, K234-02, and K514-03) 
sequenced were classified as belonging to the KM91 type 
by RFLP analysis, and these had 71.2% to 99.7% nucleo-
tide sequence identity and 71.5% to 99.3% amino acid se-
quence similarity with each other. Although these IBVs ex-
hibited identical RFLP patterns, differences in genetic 
composition might still exist that could affect their behav-
ior under field conditions.
  In the phylogenetic tree, the Korean IBV isolates exam-
ined formed three different groups. Half of the 12 Korean 
IBVs (K748-01, K044-02, K058-02, K117-02, K234-02, 
and K514-03) were classified into the IBV KM91 type, 
consistent with the result obtained by RT-PCR-RFLP anal-
ysis [21]. 
  The three IBVs K10217-03, K3-3 and K1255-03 recently 
isolated in Korea formed a distinct cluster, which was re-
lated to the KM91 type. They shared between 83.3% to 
85.2% amino acid sequence similarity with the KM91 type 
IBVs, a higher similarity with KM91 than non-Korean and 
some other Korean IBVs. These three IBVs shared a 
unique RFLP pattern, however, which had not been pre-
viously reported. Therefore, the Korean IBV K10217-03, 
K3-3 and K1255-03 isolates seem to represent a new 
Korean IBV variant. Further characterization of these IBV 
isolates by virus-neutralization testing is warranted. The 
remaining isolates K434-01, K545-02, and K2-6 were 
clustered into the Ark99 group, although K545-02 and 
K2-6 isolates were not classified into the Arkansas type by 
PCR-RFLP analysis. They showed various RFLP patterns. 
Either these strains generate two or more RFLP patterns in 
spite of belonging to the same group in phylogenetic tree 
analysis, or they may in fact consist of a mixture of two dif-
ferent kinds of viruses. Distinguishing between these pos-
sibilities will require further characterization using cloned 
viruses. 
  The evolution of IBV appears to be influenced by many 
factors, such as the use of multiple strains for vaccination, 
the population density and the host immune status [6]. In 
addition, transcription of IBV’s RNA genome has a high 
error rate [15,20]. Widespread uses of various vaccines 
made from heterologous IBVs in the field may also exert  
pressure resulting in the increase of new genetic variants in 
Korea. 
  In summary, 12 Korean field IBVs were isolated and 
found to differ from published non-Korean IBV strains in 
both nucleotide and amino acid sequences. Phylogenetic 
tree analysis revealed three distinct groups, one of which 
has not been previously reported. It appears that the IBVs 
are continuously evolving in Korea. Therefore, the in-
digenous IBV isolates should be considered as the initial 
candidates  for protection against  current IBV infections in 
chickens. Virus-neutralization and cross-challenge tests 
will be needed for further characterization of the new IBVs 
before selecting strains for a vaccine. 
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